| Devon Hornung, | |
|
602 Vonderburg Dr, Suite 201, Brandon, FL 33511-5900 | |
| (813) 653-1149 | |
| (813) 654-6644 |
| Full Name | Devon Hornung |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 602 Vonderburg Dr, Brandon, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023418621 | NPI | - | NPPES |
| 013366500 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SZ6805 (Florida) | Secondary |
| 235Z00000X | Speech-language Pathologist | SA14376 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Devon Hornung, 602 Vonderburg Dr, Suite 201, Brandon, FL 33511-5900 Ph: (813) 653-1149 | Devon Hornung, 602 Vonderburg Dr, Suite 201, Brandon, FL 33511-5900 Ph: (813) 653-1149 |
News Archive
In an advance that may potentially lead to new treatments for parasitic hookworms, scientists at the University of Massachusetts Medical School and Cornell University have sequenced the genome of the hookworm, Ancylostoma ceylanicum.
Inter Press Service examines Uganda's "controversial Counterfeit Goods Bill," which some say will limit the public's access to "life-saving generic medicines."
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
Do pharmaceutical ads educate patients and improve health - or merely spur drug sales? Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy will conduct the first comprehensive study of televised drug commercials using Nielsen Media Research and health care utilization data.
› Verified 7 days ago
Stephanie Madill, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 602 Vonderburg Dr, Suite 201, Brandon, FL 33511 Phone: 813-653-1149 Fax: 813-654-6644 | |
Mrs. Stacy Heath, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 602 Vonderburg Dr., Suite 201, Brandon, FL 33511 Phone: 813-653-1149 Fax: 813-654-6644 | |
Heather Martinez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 602 Vonderburg Dr, Suite 201, Brandon, FL 33511 Phone: 813-653-1149 Fax: 813-654-6644 | |
Monica Barcelo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 602 Vonderburg Dr, Suite 201, Brandon, FL 33511 Phone: 813-653-1149 Fax: 813-654-6644 | |
Kristen Leigh Bond, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 937 Wicketrun Dr, Brandon, FL 33510 Phone: 954-817-7499 | |
Mrs. Melissa Perkins, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 602 Vonderburg Dr, Brandon, FL 33511 Phone: 305-901-9309 |